Accelerating Drug Discovery
Location: United States, California, San Diego
Total raised: $40M
Investors 3
| Date | Name | Website |
| - | FusionX Ve... | fusionxven... |
| - | OMX Ventur... | omx.vc |
| 05.03.2021 | Vertical V... | vvp.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.02.2022 | Series A | $40M | - |
Mentions in press and media 8
| Date | Title | Description |
| 08.02.2022 | 1859 banks $40M Series A | 1859 has raised $40 million in a round co-led by Northpond Ventures and OMX Ventures. The company is the developer of an empirical screening platform designed to discover new small molecule medicines for emerging disease targets. Additional... |
| 07.02.2022 | 1859 Inc. Launches with $40 Million Series A to Industrialize New Medicine Discovery by Combining Artificial Intelligence and Empirical Screening Data at Scale | 1859, Inc., a platform company combining artificial intelligence and empirical pico-scale screening data at scale to discover new small molecule medicines for emerging disease targets, launched today and announced the close of a highly succ... |
| 07.02.2022 | 1859 Launches with $40M Series A | SAN DIEGO, CA, 1859, a platform company to discover new small molecule medicines, launched and announced the close of a Series A funding round of $40 million. >> Click here for more funding data on 1859 >> To export 1859 fun... |
| 07.02.2022 | 1859 Finds $40M For AI Powered Biotech | San Diego-based 1859, a biotech startup which says it is combining artificial intelligence with small molecule medicine screening, said on Monday that it has raised $40M in a Series A funding round. The funding came from Northpond Ventures,... |
| 07.02.2022 | 1859 Launches with $40M in Series A Funding | 1859, Inc., a San Diego, CA-based platform company combining artificial intelligence and empirical pico-scale screening data at scale to discover new small molecule medicines for emerging disease targets, launched with a Series A funding ro... |
| 07.02.2022 | San Diego’s 1859 comes out of stealth mode with $40 million to streamline drug discovery | San Diego’s 1859, a startup founded by Scripps Research Institute scientists, has come out of stealth mode with $40 million to push forward its technology platform that aims to jumpstart discovery of new medicines. Founded in 2019 and incub... |
| 30.10.2019 | Irvine tech startup cleans up at San Diego’s QuickPitch competition | An Irvine-based tech startup scored two awards — and scooped up $60,000 of the total $75,000 in award money — at one of San Diego’s most popular events for local startups. The event, called the John G. Watson Quick Pitch Competition, featur... |
| - | Biotech startup with AlphaGo-type AI approach snags $30M | In the world of artificial intelligence and machine learning, Google Deepmind’s AlphaGo program defeating world champion Lee Sedol at the game Go on March 19, 2016, was a watershed moment. It showed, among other things, that if an AI algori... |